FRESENIUS MEDICAL CARE AG Research And Development Expense
FRESENIUS MEDICAL CARE AG (FMS) reported Research And Development Expense of EUR 157.97 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG research and development expense for the quarter ending 2025-12-31 was 38.63M EUR, a 22.83% decline year-over-year.
- FRESENIUS MEDICAL CARE AG research and development expense for the quarter ending 2025-09-30 was 37.75M EUR, a 5.74% decline year-over-year.
- FRESENIUS MEDICAL CARE AG research and development expense for the quarter ending 2025-06-30 was 38.12M EUR, a 16.38% decline year-over-year.
- FRESENIUS MEDICAL CARE AG research and development expense for the quarter ending 2025-03-31 was 43.48M EUR, a 9.04% decline year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 9 month | Research And Development Expense 9 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 38.63M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 76.38M EUR derived: sum of 2 quarters · filed 2026-02-24 | 114.49M EUR derived: sum of 3 quarters · filed 2026-02-24 | 157.97M EUR 20-F · filed 2026-02-24 | ||||
| 2025-09-30 | 37.75M EUR 6-K · filed 2025-11-04 | 75.86M EUR derived: sum of 2 quarters · filed 2025-11-04 | 119.35M EUR 6-K · filed 2025-11-04 | 169.41M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2025-06-30 | 38.12M EUR 6-K · filed 2025-08-05 | 81.60M EUR 6-K · filed 2025-08-05 | 131.66M EUR derived: sum of 3 quarters · filed 2026-02-24 | 171.71M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2025-03-31 | 43.48M EUR 6-K · filed 2025-05-06 | 93.54M EUR derived: sum of 2 quarters · filed 2026-02-24 | 133.59M EUR derived: sum of 3 quarters · filed 2026-02-24 | 179.17M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-12-31 | 50.06M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 90.11M EUR derived: sum of 2 quarters · filed 2026-02-24 | 135.69M EUR derived: sum of 3 quarters · filed 2026-02-24 | 183.49M EUR 20-F · filed 2026-02-24 | ||||
| 2024-09-30 | 40.05M EUR 6-K · filed 2025-11-04 | 85.63M EUR derived: sum of 2 quarters · filed 2025-11-04 | 133.43M EUR 6-K · filed 2025-11-04 | 199.42M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | 45.59M EUR 6-K · filed 2025-08-05 | 93.39M EUR 6-K · filed 2025-08-05 | 159.37M EUR derived: sum of 3 quarters · filed 2026-02-24 | 212.41M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | 47.80M EUR 6-K · filed 2025-05-06 | 113.79M EUR derived: sum of 2 quarters · filed 2026-02-24 | 166.83M EUR derived: sum of 3 quarters · filed 2026-02-24 | 224.01M EUR derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | 65.98M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 119.03M EUR derived: sum of 2 quarters · filed 2026-02-24 | 176.21M EUR derived: sum of 3 quarters · filed 2026-02-24 | 231.97M EUR 20-F · filed 2026-02-24 | ||||
| 2023-09-30 | 53.04M EUR 6-K · filed 2024-11-05 | 110.22M EUR derived: sum of 2 quarters · filed 2024-11-05 | 165.99M EUR 6-K · filed 2024-11-05 | 228.03M EUR derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | 57.18M EUR 6-K · filed 2024-07-30 | 112.94M EUR 6-K · filed 2024-07-30 | 174.99M EUR derived: sum of 3 quarters · filed 2025-02-25 | 236.48M EUR derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | 55.76M EUR 6-K · filed 2024-05-07 | 117.81M EUR derived: sum of 2 quarters · filed 2025-02-25 | 179.29M EUR derived: sum of 3 quarters · filed 2025-02-25 | 234.71M EUR derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | 62.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 123.53M EUR derived: sum of 2 quarters · filed 2025-02-25 | 178.95M EUR derived: sum of 3 quarters · filed 2025-02-25 | 228.62M EUR 20-F · filed 2025-02-25 | ||||
| 2022-09-30 | 61.48M EUR 6-K · filed 2023-11-02 | 116.90M EUR derived: sum of 2 quarters · filed 2023-11-02 | 166.57M EUR 6-K · filed 2023-11-02 | 234.33M EUR derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | 55.42M EUR 6-K · filed 2023-08-02 | 105.09M EUR 6-K · filed 2023-08-02 | 172.85M EUR derived: sum of 3 quarters · filed 2024-02-20 | 225.21M EUR derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | 49.67M EUR 6-K · filed 2023-05-09 | 117.43M EUR derived: sum of 2 quarters · filed 2024-02-20 | 169.79M EUR derived: sum of 3 quarters · filed 2024-02-20 | 221.81M EUR derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | 67.76M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 120.12M EUR derived: sum of 2 quarters · filed 2024-02-20 | 172.14M EUR derived: sum of 3 quarters · filed 2024-02-20 | 220.78M EUR 20-F · filed 2024-02-20 | ||||
| 2021-09-30 | 52.36M EUR 6-K · filed 2022-10-31 | 104.38M EUR derived: sum of 2 quarters · filed 2022-10-31 | 153.02M EUR 6-K · filed 2022-10-31 | 205.45M EUR derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | 52.02M EUR 6-K · filed 2022-08-02 | 100.66M EUR 6-K · filed 2022-08-02 | 153.09M EUR derived: sum of 3 quarters · filed 2023-02-22 | 198.01M EUR derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | 48.65M EUR 6-K · filed 2022-05-04 | 101.07M EUR derived: sum of 2 quarters · filed 2023-02-22 | 146.00M EUR derived: sum of 3 quarters · filed 2023-02-22 | 196.50M EUR derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | 52.43M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-22 | 97.35M EUR derived: sum of 2 quarters · filed 2023-02-22 | 147.86M EUR derived: sum of 3 quarters · filed 2023-02-22 | 193.77M EUR 20-F · filed 2023-02-22 | ||||
| 2020-09-30 | 44.92M EUR 6-K · filed 2021-11-02 | 95.43M EUR derived: sum of 2 quarters · filed 2021-11-02 | 141.35M EUR 6-K · filed 2021-11-02 | 190.20M EUR derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | 50.51M EUR 6-K · filed 2021-07-30 | 96.42M EUR 6-K · filed 2021-07-30 | 145.27M EUR derived: sum of 3 quarters · filed 2022-02-22 | 187.47M EUR derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | 45.92M EUR 6-K · filed 2021-05-06 | 94.77M EUR derived: sum of 2 quarters · filed 2022-02-22 | 136.96M EUR derived: sum of 3 quarters · filed 2022-02-22 | 185.35M EUR derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | 48.85M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 91.05M EUR derived: sum of 2 quarters · filed 2022-02-22 | 139.43M EUR derived: sum of 3 quarters · filed 2022-02-22 | 168.03M EUR 20-F · filed 2022-02-22 | ||||
| 2019-09-30 | 42.20M EUR 6-K · filed 2020-10-29 | 49.17M EUR 6-K · filed 2019-10-31 | 90.58M EUR derived: sum of 2 quarters · filed 2020-10-29 | 119.18M EUR 6-K · filed 2020-10-29 | 136.59M EUR 6-K · filed 2019-10-31 | 137.97M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | 48.38M EUR 6-K · filed 2020-07-30 | 41.02M EUR 6-K · filed 2019-07-30 | 76.98M EUR 6-K · filed 2020-07-30 | 74.63M EUR 6-K · filed 2019-07-30 | 95.77M EUR derived: sum of 3 quarters · filed 2021-02-23 | 121.51M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | 28.60M EUR 6-K · filed 2020-05-06 | 33.61M EUR 6-K · filed 2019-05-02 | 47.38M EUR derived: sum of 2 quarters · filed 2021-02-23 | 73.13M EUR derived: sum of 3 quarters · filed 2021-02-23 | 110.78M EUR derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | 18.79M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 44.53M EUR derived: sum of 2 quarters · filed 2021-02-23 | 82.18M EUR derived: sum of 3 quarters · filed 2021-02-23 | 114.07M EUR 20-F · filed 2021-02-23 | 133.62M EUR 20-F · filed 2019-02-20 | |||
| 2018-09-30 | 25.74M EUR 6-K · filed 2019-10-31 | 63.39M EUR derived: sum of 2 quarters · filed 2019-10-31 | 95.29M EUR 6-K · filed 2019-10-31 | 111.36M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-06-30 | 37.65M EUR 6-K · filed 2019-07-30 | 69.55M EUR 6-K · filed 2019-07-30 | 85.61M EUR derived: sum of 3 quarters · filed 2020-02-20 | 113.31M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-03-31 | 31.90M EUR 6-K · filed 2019-05-02 | 47.97M EUR derived: sum of 2 quarters · filed 2020-02-20 | 75.66M EUR derived: sum of 3 quarters · filed 2020-02-20 | 110.76M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2017-12-31 | 16.07M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 43.77M EUR derived: sum of 2 quarters · filed 2020-02-20 | 78.86M EUR derived: sum of 3 quarters · filed 2020-02-20 | 111.00M EUR 20-F · filed 2020-02-20 | 130.70M EUR 20-F · filed 2018-02-27 | |||
| 2017-09-30 | 27.70M EUR 6-K · filed 2018-10-30 | 62.79M EUR derived: sum of 2 quarters · filed 2018-10-30 | 94.93M EUR 6-K · filed 2018-10-30 | |||||
| 2017-06-30 | 35.10M EUR 6-K · filed 2018-08-01 | 67.23M EUR 6-K · filed 2018-08-01 | ||||||
| 2017-03-31 | 32.14M EUR 6-K · filed 2018-05-03 | |||||||
| 2016-12-31 | 146.51M EUR 20-F · filed 2019-02-20 | |||||||
| 2015-12-31 | 128.13M EUR 20-F · filed 2018-02-27 |